Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wellnex Life Ltd ( (AU:WNX) ) has issued an update.
Wellnex Life reported a milestone March quarter, delivering its first positive operating cash flow since launching its turnaround strategy, driven by a 30.8% rise in customer cash receipts to $6.67 million and stringent cost controls. While quarterly revenue fell 28.2% to $5.1 million amid lower IP licensing income and reduced marketing for non-core brands, the company cut staff, advertising and administrative costs, and management is targeting stronger Q4 revenue, improved gross margins and further balance sheet strengthening.
Operating cash flow improved to a $0.41 million inflow from a $0.16 million outflow, underscoring progress in cash conversion and validating the board’s cost reduction programme. Structural savings, including a 29% quarter-on-quarter reduction in staff costs, have created a leaner organisation, and the board expects these efficiencies and a renewed marketing focus on core brands to support a stronger finish to FY26 and reinforce the company’s turnaround trajectory.
More about Wellnex Life Ltd
Wellnex Life Limited is an ASX and AIM-listed health and wellness company focused on consumer brands, including products such as Pain Away, Wakey Wakey and Nighty Night. The business generates revenue through both branded goods and intellectual property licensing, with a strategy emphasising owned brands, margin improvement and better working capital conversion in the Australian and UK markets.
Average Trading Volume: 65,793
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.48M
See more data about WNX stock on TipRanks’ Stock Analysis page.